Health and data journalist.
I cover a wide range of healthcare topics, from cutting-edge therapies to global health. My stories are often data-driven, and I strive to make complex issues clear and accessible. Before becoming a full-time journalist, I worked in communication, research, and data analysis for the UN and EU. In the private sector, I developed health economics models to inform policy and investment decisions. Originally from Italy, I am now based in Zurich.
More
Health systems
How transparent is a Swiss hospital bill really?
This content was published on
Every patient in Switzerland receives a copy of their medical bills. But while the law promises transparency, hospital invoices remain almost impossible for ordinary patients to decipher.
This content was published on
Drug development has always been expensive and risky, but now it’s measurably more so than a decade ago. Here are three reasons why.
Crans-Montana: when a medical bill is not just a bill
This content was published on
After the deadly bar fire in Crans-Montana, unexpected hospital invoices sent across the border ignited tensions between Switzerland and Italy – and revealed how systems clash when tragedy strikes.
Cured but uninsurable: the hidden financial burden of surviving cancer in Switzerland
This content was published on
More people are surviving cancer than ever before. But in Switzerland a historical diagnosis can follow former patients for years.
When sperm crosses borders, national safeguards fall short
This content was published on
The sperm of a Danish donor carried a cancer-causing genetic mutation that led to the deaths of children. Switzerland’s strict regulations make scenarios of this scale unlikely.
Under-50s cancer patients face system unprepared for them
This content was published on
Countries, including Switzerland, are struggling to deal with the challenges posed by rising cancer rates among people under 50.
How US tariffs could disrupt the generic drugs supply chain
This content was published on
US tariffs on generics could raise drug prices and accentuate shortages. That's not what US President Donald Trump had in mind.
This content was published on
Nearly 30 years ago an academic paper wrongly linked autism to a measles vaccine. The impacts are still being felt today.
Global concern over measles is rising. Should Switzerland worry?
This content was published on
Measles is making a global comeback. In Switzerland, a crisis is unlikely – but authorities warn a strong vaccination rate remains crucial.
